A case series on the efficacy and safety of a PD‐1 inhibitor combined with antiangiogenic agents in the treatment of recurrent MSI‐H endometrial cancer

Hualin Song(Tianjin Medical University Cancer Institute and Hospital), Wenxin Liu(Jiujiang University), Jing Tian(Fudan University), Huiting Xiao(Tianjin Medical University Cancer Institute and Hospital), Ke Wang(Zhejiang Chinese Medical University), Zhihua Du(Hebei University of Chinese Medicine)
Gland Surgery
August 1, 2023
Cited by 0


Related Papers